Brief: Hls Therapeutics Increases Normal Course Issuer Bid
24/09/2026 12:08
BRIEF-Hls Therapeutics Increases Normal Course Issuer Bid Sept 24 (Reuters) - HLS Therapeutics Inc HLS.TO:
HLS THERAPEUTICS INCREASES NORMAL COURSE ISSUER BID
HLS THERAPEUTICS - INCREASES NORMAL COURSE ISSUER BID TO 1,872,685 COMMON SHARES
Source text: ID:nCNWDn1RZa
Further company coverage: HLS.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on HLS Therapeutics
See all newsBrief: Hls Therapeutics Increases Normal Course Issuer Bid
Brief: HLS Therapeutics Announces Q2 2026 Financial Results
Canada's HLS Therapeutics Q2 revenue rises on higher cardiovascular drugs demand
Brief: HLS Therapeutics - Secures Nilemdo Reimbursement With Private Payers Covering 80% Of Privately Insured Canadians
Canada Research Roundup: CIBC ,HLS Therapeutics, TD Bank Group